A thorough search of databases, including Oxford Academic, PubMed, Elsevier, Journal of American Heart Association (JAHA), Frontiers, and Science Direct, was done to find relevant articles published in the last 10 years. The inclusion criteria centered on randomized controlled trials, cohort studies, and meta-analyses that examined lifestyle changes with medication in overweight and obese patients. 21 studies were chosen based on relevance, quality, and the robustness of their intervention, as shown in Figure 1 below. Data extraction included compiling information on weight reduction results, metabolic health markers, safety profiles, and patient adherence from the recognized research.

Among the notable aspects of lifestyle modifications is dietary changes. Thus, various types of diets have been examined with regard to their impacts on weight control and metabolic health. For instance, low-carbohydrate diets, including Atkins and ketogenic diets, have been acknowledged to promote a reduction in carbohydrate intake and an increment in fat consumption, prompting the body to burn fat for energy [4] . Further, the Mediterranean diet, which includes fruits, vegetables, whole grains, and healthy fats, has been acknowledged to foster cardiovascular health while aiding weight reduction [4] . Intermittent fasting has also been found to be effective in reducing the total calorie consumption and increasing insulin sensitivity [4] . Low-fat diets, previously the gold standard for weight control, limit fat intake while stressing increased consumption of carbohydrate [4] . The above diets provide distinctive approaches to macronutrient balance and calorie intake, catering to varied tastes and metabolic reactions. For instance, while certain individuals may prefer intermittent fasting as it is simple to follow owing to its regulated eating periods, others might prefer the Mediterranean diet owing to its flexibility.

Regarding the mechanisms of action for dietary changes, it is noteworthy that dietary adjustments aid weight reduction through processes that include caloric deficit and nutrient composition. Thus, a caloric deficit, where energy intake is less than energy expenditure, is key to all successful diets [4] . This shortfall causes the body to consume stored fat for energy, resulting in weight loss. Nutrient composition also plays a key role; high-protein diets may promote satiety and thermogenesis, making it simpler to sustain a calorie deficit. Low-carbohydrate diets lower insulin levels, which may promote fat burning [4] [5] . Conversely, diets high in fiber, like the Mediterranean diet, decrease stomach emptiness and prolong sensations of fullness. Intermittent fasting may promote metabolic flexibility, enabling the body to swing between burning glucose and fat more effectively [4] [5] . These diets target metabolic pathways to maximize weight reduction and enhance overall metabolic health by changing macronutrient ratios and eating habits.

Moreover, regarding the impacts on weight loss and metabolic health, it can be noted that different dietary methods have varying benefits on weight reduction and metabolic health. Low-carbohydrate diets frequently result in quick initial weight reduction owing to lower glycogen storage and accompanying water loss, and they may enhance insulin sensitivity and lipid profiles [5] - [8] . The Mediterranean diet, although low in weight reduction pace, considerably increases cardiovascular health, decreasing the risk of heart disease and stroke owing to its high quantity of anti-inflammatory foods [5] - [8] . Intermittent fasting has been found to enhance glucose metabolism, possibly lowering the incidence of type 2 diabetes. Low-fat diets, however less successful in the short term compared to low-carb diets, may nonetheless yield considerable weight reduction and improve lipid profiles over time [5] - [8] . Each diet’s efficacy in increasing metabolic health is also impacted by individual adherence, hereditary variables, and pre-existing health issues, underscoring the need for tailored dietary advice.

The other notable aspect of lifestyle modification assessed in this study is physical activity. Thus, physical activity is an essential component of weight control and metabolic health, covering aerobic workouts, strength training, and high-intensity interval training (HIIT). Aerobic workouts, such as walking, jogging, and cycling, boost cardiovascular fitness and burn calories [6] - [10] . Resistance exercises, such as weightlifting and bodyweight workouts, focus on growing muscle mass, which boosts the resting metabolic rate and promotes fat loss [6] - [10] . HIIT alternates between brief bursts of intense activity and intervals of rest or low-intensity exercise, optimizing calorie burn in a shorter time and boosting both aerobic and anaerobic performance [6] - [10] . All kinds of physical exercise have distinct advantages and may be customized to individual fitness levels and tastes, giving a complete approach to physical fitness and weight control.

Concerning the mechanisms of action, it is noteworthy that the approaches through which physical exercise benefits weight reduction and metabolic health are diverse. For instance, aerobic exercise boosts energy expenditure during activity and for a brief time, thereafter, providing a caloric deficit important for weight reduction [8] - [13] . It also promotes cardiovascular health by boosting heart and lung efficiency. Resistance exercise helps keep and grow muscle mass, which is vital for maintaining a higher resting metabolic rate, therefore supporting long-term weight control [8] - [13] . Muscle tissue burns more calories at rest compared to fat tissue, making muscle maintenance crucial for weight reduction [8] - [13] . HIIT combines the advantages of both aerobic and anaerobic training, boosting energy expenditure and enhancing metabolic flexibility [8] - [13] . The after-burn effect, or excess post-exercise oxygen consumption (EPOC), is more significant with HIIT, leading to increased calorie burn long after the session is over.

Consequently, regarding the impact of physical activity on weight loss and metabolic health, it can be noted that physical exercise greatly improves weight reduction and metabolic health. Regular aerobic exercise improves glucose metabolism, decreases the risk of type 2 diabetes, and boosts cardiovascular fitness, lowering the risk of heart disease [8] - [13] . Resistance exercise, by increasing muscle mass, improves sustained weight reduction and metabolic health by enhancing resting metabolic rate and improving body composition [8] - [13] . HIIT is especially effective in lowering visceral fat, a critical risk factor for metabolic diseases, and in increasing insulin sensitivity [8] - [13] . Physical exercise also favorably improves mental health by lowering feelings of anxiety and depression, which may indirectly benefit weight control efforts [8] - [13] . Overall, combining multiple forms of physical exercise into a lifestyle change strategy offers overall health benefits and increases the possibility for long-term weight control and enhanced metabolic health.

Lastly, pharmacotherapy as weight loss approach or strategy entails the use of various kinds of medication to reduce weight in obese and overweight persons. Thus, the most frequently employed weight reduction drugs include orlistat and GLP-1 receptor agonists such as liraglutide and semaglutide. Orlistat (Xenical, Alli) works by limiting the absorption of dietary fats in the gut, resulting in decreased calorie intake [14] [15] . GLP-1 receptor agonists, including liraglutide (Saxenda) and semaglutide (Wegovy), imitate the incretin hormone GLP-1, which stimulates insulin production, slows stomach emptying, and induces satiety [14] [15] . Other drugs, such as phentermine-topiramate (Qsymia) and naltrexone-bupropion (Contrave), can help with weight reduction by reducing appetite and boosting energy expenditure.

Regarding pharmacotherapy’s mechanisms of action, it can be noted that Orlistat’s major mode of action is the suppression of pancreatic lipase, an enzyme important for the breakdown of triglycerides in the gut. This leads to around 30% of dietary fat being excreted undigested [14] [15] . GLP-1 receptor agonists act by imitating the incretin hormone, which increases insulin production, slows stomach emptying, and suppresses hunger, resulting in decreased food consumption [14] [15] . Phentermine-topiramate operates on the central nervous system to reduce appetite, whereas naltrexone-bupropion alters the brain's reward circuits linked with food cravings.

Further, regarding the impact on weight loss and metabolic health, pharmacotherapy has been scientifically proven effective in weight reduction and enhancement of metabolic health indices. Orlistat use has been acknowledged to bring about a 5% - 10% reduction in body weight over a period of 1 year [14] [15] . However, GLP-1 receptor agonists, including liraglutide and semaglutide, have been reported to result in even higher weight reduction, with some patients losing 10% - 15% of their body weight [14] [15] . These drugs also enhance metabolic parameters, such as decreasing HbA1c levels in individuals with type 2 diabetes, lowering blood pressure, and boosting lipid profiles [14] [15] . Phentermine-topiramate and naltrexone-bupropion also indicate positive changes in metabolic health, while their principal advantages are weight reduction and suppression of appetite.

In comparing the short-term and long-term efficacy of lifestyle modifications in relation to pharmacotherapy in weight loss, our study findings have disclosed that lifestyle improvements, such as changes in diet and higher physical activity, generally lead to an average weight reduction of 5% - 10% of starting body weight between six months and years [1] - [21] . Pharmacotherapy may accelerate weight reduction beyond lifestyle modifications alone, with drugs like GLP-1 receptor agonists promoting 10% - 15% weight loss over the same time [1] - [21] . Nevertheless, maintaining the weight reduction results remains problematic for both techniques, with a substantial chance of weight rebound unless continuing intervention and support are offered.

Still, regarding the comparative impact on metabolic health outcomes, the study has disclosed that combining lifestyle adjustments and therapies improves metabolic health. Lifestyle treatments increase insulin sensitivity, and lipid profiles, and lower cardiovascular risk factors [1] - [21] . Pharmacotherapy, especially with GLP-1 receptor agonists, considerably decreases HbA1c levels and reduces the risk of cardiovascular events [1] - [21] . The combined approach of lifestyle adjustments with medicine frequently leads to better improvements in metabolic health compared to either method alone.

Further, concerning the safety profiles and side effects of pharmacotherapy, the study has disclosed that lifestyle adjustments typically have a good safety profile with few adverse effects, while excessive physical activity may lead to injury if not carefully controlled. Pharmacotherapy, although beneficial, comes with possible negative effects [1] - [21] . Orlistat may induce gastrointestinal disorders such as steatorrhea [1] - [21] . GLP-1 receptor agonists may produce nausea, vomiting, and, in rare circumstances, pancreatitis [1] - [21] . Phentermine-topiramate may increase heart rate, sleeplessness, and paresthesia, whereas naltrexone-bupropion may produce raised blood pressure and mental symptoms.

Lastly, on patient adherence and quality of life considerations, compliance with lifestyle improvements might be hard due to the major behavioral changes needed. Constant inspiration and support are vital for long-term success [1] - [21] . Pharmacotherapy may increase adherence to weight reduction regimes by giving extra help in lowering hunger and food consumption [1] - [21] . Nevertheless, side effects and the expense of drugs may hinder long-term adherence [1] - [21] . Quality of life typically improves with weight reduction via both treatments, but tailored strategies including patient preferences, lifestyle, and possible hurdles are needed for sustained success. This has been aptly captured in Table 1 .

Among the key strengths of this study include the observation that it has substantial evidence based on several randomized controlled trials and meta-analyses, offering high-quality data on the effectiveness and safety of lifestyle modifications and medication in relation to weight loss. Further, the study has also utilized long-term research, including the Diabetes Prevention Program and Look AHEAD, which has not only provided vital information but also enhanced the generalizability of the findings [17] - [20] . Regardless of the above strengths, a number of limitations have been acknowledged, including the unpredictability of patient adherence, the risk of weight gain, and the adverse drug effects [17] - [20] . Therefore, additional studies are required to understand the long-term durability of these therapies and to create techniques to increase adherence and decrease the adverse effects of treatments.

Based on the findings, there is a need for clinicians to adopt a tailored strategy when advising weight reduction treatments, and combining lifestyle adjustments with pharmacotherapies where needed. Regular follow-up and assistance are also necessary to sustain weight reduction and enhance metabolic health [17] - [20] . Educating patients on the advantages and possible adverse effects of drugs, in addition to giving them behavioral support alternatives, is more likely to boost adherence and results [17] - [20] . Patients should be encouraged to set realistic goals and participate in persistent lifestyle modifications to accomplish and sustain their weight reduction.

It is recommended that clinicians should emphasize lifestyle adjustments as the first-line therapy for obesity owing to their broad health benefits and few adverse effects. Pharmacotherapy should be explored for individuals who do not achieve substantial weight reduction with lifestyle modifications only, and also for those with obesity-related comorbidities needing more rapid interventions [18] - [20] . Furthermore, it is vital that treatment approaches are customized based on individual patient’s traits, preferences, and medical history [18] - [20] . Continuous monitoring and assistance are needed to guarantee adherence and treat any possible adverse effects of medication, enhance patient outcomes and support long-term weight control [18] - [20] .

Future research should concentrate on long-term comparative studies of lifestyle therapies and pharmacotherapy to comprehend their sustained impact on weight reduction and metabolic health. There is a demand for more varied research populations to boost the generalizability of results across various age groups, ethnicities, and concomitant disorders. Furthermore, researching the integration of digital health technology and behavioral support systems with these therapies might give insights into enhancing patient adherence and results. Investigating the combined impact of lifestyle modifications and medicines might reveal methods for more effective and comprehensive obesity treatment.